Background Previous studies have indicated that ramosetron, a 5-hydroxytryptamine-3
receptor antagonist, achieves global improvement in irritable bowel syndrome (IBS) …

Introduction: Irritable bowel syndrome (IBS) is one of the most common gastrointestinal
disorders with a 9–23% prevalence estimated in the general population. Patients can be …

To verify the clinical efficacy and safety of the proven Chinese Compound Changjitai (CJT),
in treating the diarrheic irritable bowel syndrome (DIBS). Randomized controlled open …

Background: Irritable bowel syndrome (IBS) has a high morbidity rate worldwide, but there
are no effective treatment measures, which seriously affect people's lives. Previous clinical …

Background Irritable bowel syndrome (IBS) is characterized by chronic, recurrent abdominal
pain or abdominal discomfort and changes in defecation habits. Xiang-Sha-Liu-Jun-Zi tang …

Introduction Chinese herbal medicine (CHM) and probiotics are two complementary and
alternative approaches often used for irritable bowel syndrome (IBS). This study evaluates …

Introduction: Irritable bowel syndrome with diarrhea (IBS-D) is among the most common
functional gastrointestinal (GI) disorders and is associated with impaired quality of life …

Objective To systematically evaluate the efficacy and safety of acupuncture on diarrhea-
predominant irritable bowel syndrome (IBS) in the past five years. Methods Online …

Objective To investigate the efficacy of integrated traditional Chinese medicine (TCM) with
Western medicine in treatment of diarrhea type irritable bowel syndrome (IBS-D) and its …

Irritable bowel syndrome (IBS) is one of the most common disorders of the gut-brain axis,
which affects approximately 4% of the global population. The Rome IV criteria define IBS as …